Purchase Order 75N98023P03121
- Not listed
- The Department of Health and Human Services National Institutes of Health National Institute on Deafness and Other Communication Disorders awarded a $24,383 firm fixed price purchase order to 10X Genomics, Inc. for CHROMIUM NEXT GEM SINGLE CELL 3' KIT V3.1, 16 reactions. Performance will take place in Pleasanton, California over a one year period from November 2021 through November 2022. The award is associated with research into single cell analysis being conducted by the funding agency. 10X...
- This is a $24,910.17 firm fixed price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD) to 10X Genomics, Inc. The contract is for the delivery of Chromium Next GEM Single Cell ATAC kits and Chromium Next GEM Chip H Single Cell kits, which support advanced genomic analysis capabilities. The award is not associated with a larger contract vehicle and does not utilize a set-aside designation. 10X Genomics, a for-profit manufacturer of...
- This is a firm fixed-price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc. for the supply of Chromium Next GEM Single Cell ATAC Kits, Chromium Next GEM Chips, and related shipping. The contract has a ceiling value of $24,776.17 and a performance period through May 20, 2026. 10X Genomics is a life sciences technology company that specializes in advanced...
- The National Institute on Deafness and Other Communication Disorders awarded a firm fixed-price Blanket Purchase Agreement (BPA) call to 10X Genomics, Inc. for a Chromium GEM-X Single Cell 3' Kit V4 (16 reactions) valued at $22,585.50. The award was made on April 13, 2022, with an ultimate completion date of January 31, 2026. This contract carries no set-aside designation and is being performed at the vendor's facility in Pleasanton, California. 10X Genomics is a leading biotechnology company...
- This firm fixed price contract was awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, to 10X Genomics, Inc., a life sciences technology company. The $23,832.00 award is for the Chromium GEM-X Single Cell 3' Kit V4, which will be used by NIDCD investigators to perform single cell captures for their research. This contract does not have a set-aside...
- This purchase order award from the Department of Health and Human Services' National Institutes of Health to 10X Genomics, Inc. is for the delivery of $151,736.32 worth of reagents compatible with 10X Genomics' Chromium Controller single-cell platform. The solicitation requested a variety of single-cell analysis kits, including for RNA sequencing, ATAC sequencing, and multi-omics techniques, to support research into neurological diseases being performed by NIH's National Institute of...
- The Department of Health and Human Services National Institutes of Health National Institute on Deafness and Other Communication Disorders awarded a $24,324 firm fixed price blanket purchase agreement call contract to 10X Genomics, Inc. for the delivery of 16 reactions of Chromium Next Gem Single Cell 3' Kits Version 3.1. As the prime contractor, 10X Genomics will provide its proprietary single cell gene expression analysis products from its Pleasanton, California location to support the NIH...
- 10X Genomics, Inc. was awarded a $24,324 firm fixed price blanket purchase agreement call contract by the National Institute on Deafness and Other Communication Disorders (NIDCD), a component of the National Institutes of Health within the Department of Health and Human Services. Under this contract, 10X Genomics will provide Chromium Next Gem single cell 3' kits containing reagents required for performing single cell captures to support research being conducted by NIDCD investigators. The one...
- This firm fixed price purchase order was awarded to 10X Genomics, Inc. (doing business as 10X Genomics) by the National Institute of Child Health and Human Development, a civilian agency within the U.S. Department of Health and Human Services, for the provision of Chromium Next GEM Reagent Bundles in the amount of $21,645.00. The award has an ultimate completion date of September 30, 2023 and did not utilize a set-aside designation. 10X Genomics is a life sciences technology company that...
- This is a $78,775.00 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to 10X Genomics, Inc. for the purchase of Chromium Next GEM cell kits. The award was made through a full and open solicitation under FAR Part 13 - Simplified Acquisition Procedures, with no set-aside designation. The contract aims to supply 10X Genomics' genomic analysis platforms, reagents, and associated services to support biomedical...
This purchase order awarded by the National Institutes of Health's National Institute on Deafness and Other Communication Disorders to 10X Genomics, Inc. is for $59,001 and covers the period from October 1, 2023 through December 22, 2023. The award is for Chromium Next Gen Single Cell Reagents Kits to support sequence analysis of patient samples using an existing 10X Genomics unit owned by NIDCD. No other reagents will be compatible with the unit. As the only known responsible source able to meet the requirement, 10X Genomics will deliver its Chromium Next GEM Single Cell 3 HT Reagents Kits to allow the agency to advance its research on deafness and other communication disorders through single cell analysis techniques over the four month period of performance.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Chromium Next Gen Single Cell Reagents Kit | SS-NIH-6725087 | Department of Health and Human Services National Institutes of Health Office of Logisitics and Acquisition Operations | Special Notice 1/1 | 9/7/23, 2:08 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $59.0k | 9/13/23 |